跳至主要内容
临床试验/NCT04035174
NCT04035174撤回不适用

Evaluation of the Diagnosis Performances of DEC LTS-2 Skin Patch for Onchocerciasis in Central Africa

Center for Research on Filariasis and Other Tropical Diseases, Cameroon1 个研究点 分布在 1 个国家目标入组 1,400 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
1,400
试验地点
1
主要终点
Feasibility of the patch

研究概览

简要总结

This study aims at evaluating the diagnosis performances of the LTS-2 DEC patch for onchocerciasis compared to the gold standard which are the skin snips. This study will be conducted in Cameroon in two different areas : Ngog-Mapubi and Bafia Health Districts (one area only endemic for onchocerciasis, and one area endemic for both loiasis and onchocerciasis).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

盲法说明

Results from LTS-2 patch will be immediately known by both participant and investigators ; but results from skin snips will be masked both for participant and investigators.

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All voluntary adults

排除标准

  • General acute infection (temperature ≥ 38,5°C)
  • Impaired general condition
  • Ivermectin taken in the 6 last months
  • Known allergies to one of the component of the patch
  • Dermatological acute infection (bacterial, atopic, prurigo, or zona)

结局指标

主要结局

Feasibility of the patch

时间窗: 24 hours

Proportion of individuals for whom the patches are spontaneously removed from the skin during the 24 hours.

Tolerability of the patch

时间窗: 24 hours

Proportion of individuals having developed a generalized Mazzotti's reaction

次要结局

  • Diagnosis performances(24 hours)
  • Loiasis and cross-reactivity assessment(24 hours)
  • Semi-quantitative scoring of the LTS-2 DEC patch results(24 hours)

研究者

发起方
Center for Research on Filariasis and Other Tropical Diseases, Cameroon
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验